EverHint – EMA 10 + Price + MACD – Top 8 Signals for Aug 05, 2026
Excerpt: 8 signals. Healthcare leads (2). price range $17-$381. 3 with insider selling.
What This Signal Is
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
Market Context
The VIX sitting at 15.71, down nearly 5% on the day, signals a meaningful compression in implied volatility — a constructive backdrop for momentum-based strategies like EMA/MACD crossover systems. Lower volatility generally tightens intraday price swings, which can improve signal reliability by reducing false breakouts and whipsaw conditions. For trend-following signals, this environment tends to reward patience, as price moves are more likely to follow through rather than reverse sharply.
The mixed index performance tells an interesting story about risk appetite. The Dow's modest gain alongside Nasdaq's near-1% decline suggests rotation away from high-growth, rate-sensitive names and toward more defensive or value-oriented segments. This divergence is worth noting when evaluating EMA-based signals, as the underlying trend strength may vary significantly depending on where within the market a signal is generated. MACD confirmation becomes especially valuable in this environment to distinguish genuine momentum from sector-level noise.
Healthcare emerging as the top sector for today's signals aligns well with the current rotational tone. Defensive sectors like Healthcare tend to attract capital when growth sectors face pressure, providing a more stable trending environment for technical setups. EMA crossovers in sectors with steady institutional inflows tend to produce cleaner signals with lower drawdown risk, making today's Healthcare-heavy signal batch particularly well-suited to the prevailing market conditions.
🟢 Buy Signals (8 of 8 total)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | ARR | ARMOUR Residential REI... | Real Estate | $16.63 | — | $1.9B |
| 2 | BNTX | BioNTech SE | Healthcare | $92.18 | — | $23.2B |
| 3 | CNR | Core Natural Resources... | Energy | $83.68 | — | $4.2B |
| 4 | RL | Ralph Lauren Corporation | Consumer Cyclical | $380.78 | — | $23.2B |
| 5 | TVTX | Travere Therapeutics, ... | Healthcare | $62.76 | — | $5.8B |
| 6 | WBD | Warner Bros. Discovery... | Communication Services | $25.97 | -$298,242 | $65.1B |
| 7 | WTTR | Select Water Solutions... | Energy | $22.26 | -$52,079,252 | $2.4B |
| 8 | YUM | Yum! Brands, Inc. | Consumer Cyclical | $152.37 | -$146,816 | $42.0B |
Field Notes
Sector concentration: Healthcare (2), Energy (2), Consumer Cyclical (2)
Insider selling: YUM (Yum! Brands, Inc., -$146,816), WTTR (Select Water Solutions, Inc., -$52,079,252), WBD (Warner Bros. Discovery, Inc., -$298,242)
Data coverage: 50.0% insider, 12.5% congressional, 0.0% earnings, 50.0% news
Peer Analysis
TVTX (Travere Therapeutics, Inc.): Leads 5 peers: CGON ($72.42), TARS ($61.29), CELC ($92.92), XENE ($64.30), AAPG ($16.86)
WTTR (Select Water Solutions, Inc.): Leads 5 peers: SPH ($17.86), MSEX ($57.35), CWCO ($29.71), EDN ($25.56), YORW ($30.82)
YUM (Yum! Brands, Inc.): Leads 5 peers: CMG ($34.49), LVS ($45.85), CPRT ($28.91), EBAY ($111.15), CCL ($29.67)
RL (Ralph Lauren Corporation): Leads 5 peers: IHG ($160.72), SW ($48.47), LULU ($123.51), CASY ($852.86), AMCR ($47.75)
CNR (Core Natural Resources, Inc.): Leads 5 peers: HCC ($84.30), BTU ($22.80), ARLP ($25.40), MGY ($23.72), UGP ($6.26)
Congressional Activity
WBD (Warner Bros. Discovery, Inc.) 🔴 Bearish
- 1 sale by 1 member
Recent Headlines
ARR (ARMOUR Residential REIT, Inc.)
- SpaceX (SPCX) Reports Strong Q2 Results Amid High Capital Expenditure Concerns
- Rockwell Automation Inc (ROK) (Q3 2026) Earnings Call Highlights: Strong Growth and Raised Guidance Amid Inflation Pressures
BNTX (BioNTech SE)
- BioNTech SE (BNTX) Q2 2026 Earnings Call Transcript
- BioNTech Q2 Earnings Call Highlights
- BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update
- BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer
CNR (Core Natural Resources, Inc.)
- Canadian National Railway (TSE:CNR) Shares Cross Above 200-Day Moving Average – Here’s Why
RL (Ralph Lauren Corporation)
- Why Ralph Lauren (RL) is Poised to Beat Earnings Estimates Again
- Curious about Ralph Lauren (RL) Q1 Performance? Explore Wall Street Estimates for Key Metrics
- These 2 Consumer Discretionary Stocks Could Beat Earnings: Why They Should Be on Your Radar
Vlad's Take
Today's signals: 3 signals showing insider selling warrant caution.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.